Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,485 across all filing types
Latest filing 2017-04-10 Transaction in Own Shar…
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2017
Transaction in Own Shares Classification · 100% confidence The document explicitly states it contains 'Transaction data in relation to Coloplast's share buy-back programme' for a specific week (week 14, April 2017). It details the number of shares bought, prices, and references the EU regulation for share buyback programmes. This content directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase activities.
2017-04-10 English
Aktietilbagekøb uge 14/2017
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from Coloplast regarding the execution of transactions under their share buy-back programme. It provides a table of specific share purchase dates, volumes, and prices, and updates the total number of treasury shares held by the company. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2017-04-10 English
Aktietilbagekøb uge 14/2017
Transaction in Own Shares Classification · 98% confidence The document is an announcement detailing Coloplast’s executed share repurchases under its buy-back programme, including dates, number of shares, prices, and accumulated treasury shares. This constitutes a report of the company buying back its own shares, matching the definition of “Transaction in Own Shares.”
2017-04-10 English
Aktietilbagekøb uge 14/2017
Transaction in Own Shares Classification · 100% confidence The document contains detailed transactional data related to Coloplast's share repurchase program for a specific week in April 2017. It includes dates, quantities, prices, and execution details of share buybacks. The content is focused on the company's repurchase of its own shares, with no indication of financial results, management commentary, or other report types. This matches the definition of a Transaction in Own Shares (POS) filing, which reports on the company's buying back or selling its own shares. The document length is substantial and contains actual transaction data, not just an announcement or summary, confirming it is a POS filing.
2017-04-10 English
Aktietilbagekøb uge 14/2017
Transaction in Own Shares Classification · 100% confidence The document is a notification from Coloplast regarding transactions made under their share buyback program. It details specific dates, the number of shares purchased, the purchase price, and the total amount spent, which is a direct report of the company buying back its own shares. This fits the definition of 'Transaction in Own Shares' (POS).
2017-04-10 English
Transaction in Own Shares 2017
Transaction in Own Shares Classification · 100% confidence The document is an official announcement dated April 3, 2017, detailing specific transactions executed by Coloplast related to its share buy-back programme between March 27 and March 31, 2017. It explicitly lists the number of shares bought and the price paid, and concludes by stating the current holding of treasury shares. This content directly corresponds to the definition of a report detailing the company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category (POS). The document length is short (3570 chars), but it is a primary report of transactions, not an announcement *about* a report, thus POS is preferred over RPA/RNS.
2017-04-03 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.